Compounds > epirubicin
Page last updated: 2024-08-23

epirubicin and Nervous System Disorders

epirubicin has been researched along with Nervous System Disorders in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aldrighetti, D; Baldini, E; Bolognesi, A; Bruzzi, P; Carnino, F; Conte, PF; Costantini, M; Giannessi, P; Guarneri, V; Mammoliti, S; Moyano, A; Prochilo, T; Rosso, R; Salvadori, B; Venturini, M1
Avilés, A; Castañeda, C; Cleto, S; Nambo, MJ; Neri, N1
Fabian, A1
Cho, KH; Choi, SM; Kim, BC; Kim, MK; Lee, SH; Yang, YS1
Bezwoda, WR1

Trials

4 trial(s) available for epirubicin and Nervous System Disorders

ArticleYear
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: results for the Gruppo Oncologico Nord Ovest randomized trial.
    Cancer, 2004, Aug-15, Volume: 101, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Humans; Middle Aged; Neoplasm Metastasis; Nervous System Diseases; Neutropenia; Paclitaxel; Quality of Life

2004
Rituximab and dose dense chemotherapy in primary breast lymphoma.
    Haematologica, 2007, Volume: 92, Issue:8

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Immunotherapy; Lymphoma, Non-Hodgkin; Middle Aged; Nervous System Diseases; Prednisone; Rituximab; Survival Analysis; Treatment Outcome; Vincristine

2007
[Evaluation of nervous system disorders during the course of gastric carcinoma on the basis of clinical electrophysiologic analysis].
    Annales Academiae Medicae Stetinensis, 1999, Volume: 45

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Electrophysiology; Epirubicin; Etoposide; Evoked Potentials, Auditory; Evoked Potentials, Auditory, Brain Stem; Evoked Potentials, Visual; Female; Fluorouracil; Humans; Male; Middle Aged; Nervous System Diseases; Paraneoplastic Syndromes; Stomach Neoplasms

1999
Treatment of advanced ovarian cancer: a randomised trial comparing adriamycin or 4'epi-adriamycin in combination with cisplatin and cyclophosphamide.
    Medical and pediatric oncology, 1986, Volume: 14, Issue:1

    Topics: Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Heart Diseases; Hematologic Diseases; Humans; Nausea; Neoplasm Staging; Nervous System Diseases; Ovarian Neoplasms; Random Allocation; South Africa

1986

Other Studies

1 other study(ies) available for epirubicin and Nervous System Disorders

ArticleYear
5-fluorouracil-induced leukoencephalopathy in patients with breast cancer.
    Journal of Korean medical science, 2001, Volume: 16, Issue:3

    Topics: Adenocarcinoma, Mucinous; Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Brain; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Glucocorticoids; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Nervous System Diseases; Prednisolone; Radiography

2001